AJMC   |   CardiologyReviewOnline   |   HCPLive   |   MDNGLive   |   OBTNLive   |   PFNLive   |   PharmacyTimes   |   C & E Politics    
 
 
Fact:   A sneeze generates a wind of 100 mi/hr, and a cough moves out at 60 mi/hr.
       Link Code
 
  E-mail Address  
  Password  
 
•   Register
 
  • Advertisement
  • Participating Faculty
     
    Published on Oct 01, 2005

    Article Tools:     Delicious          

    This supplement to The American Journal of Managed Care includes information on controlling asthma outcomes, symptoms, and treatment strategies. It has been peer reviewed by an expert in the field.

    Faculty

    Principal Authors

    Donald A. Bukstein, MD
    Director, Allergy and Asthma Research
    Dean Medical Center
    Assistant Clinical Professor
    Department of Pediatrics and Family Practice
    University of Wisconsin
    Madison, Wisconsin

    Craig A. Jones, MD
    Assistant Professor of Clinical Pediatrics
    Keck School of Medicine
    University of Southern California
    Los Angeles, California

    Dennis K. Ledford, MD
    Professor of Medicine
    University of South Florida
    Tampa, Florida

    Peter Smith, MD
    Chief, Division of Pulmonary Medicine
    Long Island College Hospital
    Professor of Clinical Medicine
    SUNY Downstate Medical Center
    Brooklyn, New York

    Michael E. Wechsler, MD
    Instructor in Medicine
    Harvard School of Medicine
    Associate Physician
    Brigham and Women's Hospital
    Boston, Massachusetts

    Contributing Author

    Frank L. Urbano, MD, FACP
    Mount Laurel Primary Care Physicians
    Mount Laurel, New Jersey

    Disclosure Statement

    PRIME® Disclosure Statement

    PRIME® holds the standard that its continuing medical education programs be free of commercial bias. The faculty have been asked to disclose any relationship they have with companies producing pharmaceuticals, medical equipment, etc, that might be germane to their contribution(s) to this CME/CE activity or any relationship they have with the commercial supporter of the program. These disclosures are not intended to suggest or condone bias but are elicited to provide participants with information that might be of potential importance in their evaluation of the program. The faculty has reported receiving something of value from a company whose product may be germane to the content of the program. Something of value refers to an equity position, vested interest, receipt of royalties, consultantship, funding by a research grant, honoraria received for educational services, or any other relationship to a company that provides sufficient reason for disclosure. The content of this CME activity may contain discussions of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

    It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

    These participants disclose the following:

    • Donald A. Bukstein, MD
        Consultant to/participated in physician education programs/served on asthma advisory boards for/and/or has been a member of speakers' bureaus for:
      • American Academy of Allergy, Asthma, and Immunology
      • American College of Allergy, Asthma, and Immunology
      • American College of Chest Physicians
      • American Lung Association
      • American Thoracic Society
      • AstraZeneca
      • Genentech
      • GlaxoSmithKline
      • Merck & Co, Inc
      • Novartis
      • Sanofi-Aventis Pharmaceuticals
      • Schering-Plough
    • Craig A. Jones, MD
        Grant/research support from:
      • Genentech
      • Merck

        Consultant to:
      • Critical Therapeutics
      • Genentech
      • Merck
      • Sanofi-Aventis

        Speakers' bureau for:
      • AstraZeneca
      • Genentech
      • Merck
      • Novartis
    • Dennis K. Ledford, MD
        Grant/research support from:
      • Baylor
      • Genentech
      • GlaxoSmithKline
      • Novartis

        Consultant for:
      • Genentech
      • Medpointe

        Clinical investigator for:
      • Genentech
      • GlaxoSmithKline
      • Medpointe
      • Novartis

        Speaker's bureau for and major stockholder with:
      • AstraZeneca
      • Genentech
      • GlaxoSmithKline
      • Merck
      • Novartis
      • Sanofi-Aventis
      • Schering
    • Peter Smith, MD
        Consultant for:
      • Genentech
      • GlaxoSmithKline
      • Novartis

        Speakers' bureau for:
      • Boehringer-Ingelheim
      • GlaxoSmithKlein
      • Novartis/Genentech
      • Pfizer
    • Michael E. Wechsler, MD
        Consultant to:
      • GlaxoSmithKline
      • Merck
      • Novartis/Genentech

        Research support from:
      • Merck

        Speakers' bureau for:
      • Boehringer-Ingelheim/Pfizer
      • GlaxoSmithKline
      • Merck
      • Novartis-Genentech
    • Frank L. Urbano, MD, FACP
        Dr Urbano discloses that he is the medical director for PRIME®, the accredited provider of this CME activity.


     
     
 
   
The Network

AJMC   |   CardiologyReviewOnline   |   HCPLive   |   MDNGLive   |   OBTNLive   |   PFNLive   |   PharmacyTimes   |   C & E Politics

copyright © MDNG. 2006 - 2008 Intellisphere, LLC    All Rights Reserved.